tüüp : |
ajaleht |
|
uurimisrühmad : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
Autor : |
Ensom MHH, Decarie D, Sheppard I. |
pealkiri : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
publikatsioon : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
Tõendite tase : |
|
füüsikaline stabiilsus : |
|
Keemiline püsivus : |
|
Muud meetodid : |
|
Kommentaarid : |
|
ingredientide nimekiri
Lansoprazole
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
|
25°C |
|
91 |
|
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
25°C |
|
91 |
|
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
|
4°C |
|
91 |
|
|
|
|
|
|
150 mg ®=? (Abbott Laboratories) |
NaHCO3 8.4% |
25 ml |
NaOH |
1N = 1.7 ml |
OraPlus® / OraSweet® (1:1) |
23.3 ml |
pH= |
8.4 |
|
4°C |
|
91 |
|
|
|
|
|